Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
CGC Genetics Unilabs Portugal | 1 | 121 |
|
Bone Marrow Failure Syndrome Panel CGC Genetics Unilabs Portugal | 1 | 175 |
|
Mendelics Brazil | 1 | 51 |
|
Thrombocytopenia panel. 34-gene NGS panel. Genologica Medica Spain | 53 | 34 |
|
Platelet function disorder panel. NGS panel of 21 genes. Genologica Medica Spain | 23 | 21 |
|
Bleeding disorder / coagulopathy panel. NGS panel of 62 genes. Genologica Medica Spain | 96 | 62 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Comprehensive Bleeding Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 80 | 66 |
|
NBEAL2 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Versiti Diagnostic Laboratories Versiti, Inc United States | 1 | 1 |
|
Thrombocytopenia Genetic Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 20 | 26 |
|
Comprehensive Platelet Disorder Panel Versiti Diagnostic Laboratories Versiti, Inc United States | 60 | 63 |
|
Inherited Thrombocytopenia Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 1 | 31 |
|
NewbornDx Advanced Sequencing Evaluation Athena Diagnostics United States | 1 | 1722 |
|
Bleeding disorder (platelet-type): Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 23 | 20 |
|
Fulgent Genetics United States | 74 | 44 |
|
Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel Fulgent Genetics United States | 146 | 82 |
|
Gray Platelet Syndrome (NBEAL2 Single Gene Test) Fulgent Genetics United States | 1 | 1 |
|
Blueprint Genetics Finland | 1 | 34 |
|
Comprehensive Hematology Panel Blueprint Genetics Finland | 4 | 239 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.